Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAaIyHHgOyHTcBL3vtN0fd051dsE8ciJoCSyYpH81lFfc#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _5 label "Selventa" provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.
- _4 value "The c-MET serves as an attractive therapeutic target in SCLC, as shown through small interfering RNA (siRNA) and selective prototype c-MET inhibitor SU11274, inhibiting the phosphorylation of c-MET itself and its downstream molecules such as AKT, S6 kinase, and ERK1/2. The HGF-stimulated phosphorylation of the following downstream phosphokinases was inhibited by SU11274: p-ERK1 [T202/Y204], p-ERK1/2 [T185/Y187], p-MEK1/2 [S221/S225], p38a p-MAP kinase [T180/Y182], p-AKT1 [S473], p-RB [S672], p-adducin-g [S662], and p-CREB [S133]). SU11274 was also effective in abrogating the inhibitory effect of HGF on the specific phosphorylation of p-PKCa [S657], p-PKCa/b [T368], and p-CDK1 [T14/Y15] (Figure 6B)." provenance.
- _4 wasQuotedFrom 17667909 provenance.
- assertion hadPrimarySource 17667909 provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- assertion wasDerivedFrom _4 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- large_corpus.bel authoredBy _5 provenance.
- large_corpus.bel version "20131211" provenance.